| Title |
Published on |
Year |
| GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders |
NEUROPHARMACOLOGY |
2023 |
| Changes in mGlu5 Receptor Signaling Are Associated with Associative Learning and Memory Extinction in Mice |
LIFE |
2022 |
| The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia |
NEUROPHARMACOLOGY |
2022 |
| mGlu3 receptor regulates microglial cell reactivity in neonatal rats |
JOURNAL OF NEUROINFLAMMATION |
2021 |
| Group I metabotropic glutamate receptor-mediated long term depression is disrupted in the hippocampus of WAG/Rij rats modelling absence epilepsy. |
NEUROPHARMACOLOGY |
2021 |
| MGlu3 receptor regulates microglial cell reactivity in neonatal rats. |
JOURNAL OF NEUROINFLAMMATION |
2021 |
| The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia |
SCHIZOPHRENIA BULLETIN |
2020 |
| Targeting mGlu Receptors for Optimization of Antipsychotic Activity and Disease-Modifying Effect in Schizophrenia |
FRONTIERS IN PSYCHIATRY |
2019 |
| Targeting metabotropic glutamate receptors in the treatment of primary brain tumors |
CURRENT OPINION IN PHARMACOLOGY |
2018 |
| Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system |
NEUROPHARMACOLOGY |
2018 |
| Targeting mGlu5 metabotropic glutamate receptors in the treatment of cognitive dysfunction in a mouse model of phenylketonuria |
FRONTIERS IN NEUROSCIENCE |
2018 |
| In vivo non-radioactive assessment of mGlu5 receptor-activated polyphosphoinositide hydrolysis in response to systemic administration of a positive allosteric modulator. |
FRONTIERS IN PHARMACOLOGY |
2018 |
| Targeting metabotropic glutamate receptors in the treatment of primary brain tumors |
CURRENT OPINION IN PHARMACOLOGY |
2018 |
| Paradoxical sleep deprivation in rats causes a selective reduction in the expression of type-2 metabotropic glutamate receptors in the hippocampus |
PHARMACOLOGICAL RESEARCH |
2017 |
| Type-7 metabotropic glutamate receptors negatively regulate α1-adrenergic receptor signalling |
NEUROPHARMACOLOGY |
2017 |
| Type-7 metabotropic glutamate receptors negatively regulate α1-adrenergic receptor signalling |
NEUROPHARMACOLOGY |
2017 |
| BDNF rs6265 methylation and genotype interact on risk for schizophrenia |
EPIGENETICS |
2016 |
| Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors |
NEUROPHARMACOLOGY |
2016 |
| Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors |
NEUROPHARMACOLOGY |
2016 |
| Xanthurenic Acid Activates mGlu2/3 metabotropic glutamate receptors and is a potential trait marker for schizophrenia |
SCIENTIFIC REPORTS |
2015 |
